Engene Holdings Inc (ENGN)

Dec 21, 2024

Engene Holdings Faces Regulatory Challenges and Business Risks Amid Clinical Trial Hurdles - TipRanks

Dec 21, 2024

Dec 20, 2024

enGene Holdings Inc. (ENGN) Upgraded to Strong Buy: Here's Why - MSN

Dec 20, 2024

Dec 20, 2024

enGene Holdings inks $100M share sale deal with Jefferies - Investing.com

Dec 20, 2024

Dec 20, 2024

EnGene : Material Agreement Form 8 K - Marketscreener.com

Dec 20, 2024

Dec 20, 2024

Form 424B5 enGene Holdings Inc. - StreetInsider.com

Dec 20, 2024

Dec 20, 2024

EnGene Holdings Inc. Reports Earnings Results for the Full Year Ended October 31, 2024 - Marketscreener.com

Dec 20, 2024

Dec 19, 2024

enGene Reports Full Year 2024 Financial Results and Provides a Business Update - BioSpace

Dec 19, 2024

Dec 19, 2024

(ENGN) Technical Pivots with Risk Controls - Stock Traders Daily

Dec 19, 2024

Dec 19, 2024

enGene Holdings Inc. (ENGN) reports earnings - Quartz

Dec 19, 2024

Dec 19, 2024

enGene (NASDAQ:ENGN) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Dec 19, 2024

Dec 19, 2024

enGene Reports Promising 71% Response Rate in Bladder Cancer Trial, Strong $298M Cash Position - StockTitan

Dec 19, 2024

Dec 15, 2024

enGene Holdings: Compelling Early Data Bode Well For Their Near-Term Outlook (NASDAQ:ENGN) - Seeking Alpha

Dec 15, 2024

Dec 14, 2024

Here's Why enGene Holdings Inc. (ENGN) is Poised for a Turnaround After Losing -16.9% in 4 Weeks - MSN

Dec 14, 2024

Dec 09, 2024

(ENGN) Investment Analysis - Stock Traders Daily

Dec 09, 2024

Dec 09, 2024

Point72 Asset Management L.P. Has $4.38 Million Holdings in enGene Holdings Inc. (NASDAQ:ENGN) - MarketBeat

Dec 09, 2024

Dec 09, 2024

enGene’s (ENGN) Market Outperform Rating Reiterated at JMP Securities - Defense World

Dec 09, 2024

Dec 07, 2024

enGene's (ENGN) Market Outperform Rating Reiterated at JMP Securities - MarketBeat

Dec 07, 2024

Dec 06, 2024

enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat

Dec 06, 2024

Dec 03, 2024

Critical Comparison: OKYO Pharma (NASDAQ:OKYO) versus enGene (NASDAQ:ENGN) - Defense World

Dec 03, 2024

Nov 28, 2024

Contrasting Immunovant (NASDAQ:IMVT) and enGene (NASDAQ:ENGN) - Defense World

Nov 28, 2024

Nov 27, 2024

Raymond James Initiates Coverage of enGene Holdings (ENGN) with Outperform Recommendation - MSN

Nov 27, 2024

Nov 27, 2024

enGene (NASDAQ:ENGN) Earns Outperform Rating from Analysts at Raymond James - MarketBeat

Nov 27, 2024

Nov 27, 2024

Recent uptick might appease enGene Holdings Inc. (NASDAQ:ENGN) institutional owners after losing 4.2% over the past year - Simply Wall St

Nov 27, 2024

Nov 25, 2024

enGene to Participate in Upcoming Investor Conferences - Vulcan Advocate

Nov 25, 2024

Nov 25, 2024

enGene Holdings to Present Cancer Treatment Updates at Major Healthcare Conferences - StockTitan

Nov 25, 2024

Nov 18, 2024

enGene (NASDAQ:ENGN) Coverage Initiated at JMP Securities - MarketBeat

Nov 18, 2024

Nov 18, 2024

JMP bullish on Engene stock as non-viral bladder cancer therapy gains traction By Investing.com - Investing.com South Africa

Nov 18, 2024

Nov 18, 2024

JMP bullish on Engene stock as non-viral bladder cancer therapy gains traction - Investing.com India

Nov 18, 2024

Nov 18, 2024

This TechnipFMC Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Nov 18, 2024

Nov 18, 2024

(ENGN) Trading Advice - Stock Traders Daily

Nov 18, 2024

Nov 17, 2024

With 52% ownership of the shares, enGene Holdings Inc. (NASDAQ:ENGN) is heavily dominated by institutional owners - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

Blue Owl Capital Holdings LP Increases Stake in enGene Holdings Inc - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

enGene files $300M mixed securities shelf - TipRanks

Nov 13, 2024

Nov 11, 2024

enGene Holdings Inc. (NASDAQ:ENGN) Receives $33.67 Consensus PT from Brokerages - MarketBeat

Nov 11, 2024

Nov 07, 2024

How the (ENGN) price action is used to our Advantage - Stock Traders Daily

Nov 07, 2024

Nov 06, 2024

enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference - BioSpace

Nov 06, 2024

Nov 05, 2024

enGene to Present Breakthrough Cancer Therapy at Guggenheim Healthcare Conference - StockTitan

Nov 05, 2024

Nov 02, 2024

Forbion growth opportunities fund acquires $4.99m in Engene Holdings shares - Investing.com Australia

Nov 02, 2024

Nov 01, 2024

Forbion growth opportunities fund acquires $4.99m in Engene Holdings shares By Investing.com - Investing.com South Africa

Nov 01, 2024

Nov 01, 2024

FY2024 EPS Estimates for enGene Boosted by Leerink Partnrs - MarketBeat

Nov 01, 2024

Oct 28, 2024

EnGene Announces $60 Million Private Placement Financing - Marketscreener.com

Oct 28, 2024

Oct 27, 2024

enGene Holdings Inc. (NASDAQ:ENGN) Sees Significant Growth in Short Interest - MarketBeat

Oct 27, 2024

Oct 26, 2024

enGene secures $60 million in private placement By Investing.com - Investing.com Canada

Oct 26, 2024

Oct 25, 2024

enGene Announces $60 Million Private Placement Financing - citybiz

Oct 25, 2024

Oct 25, 2024

Why enGene Holdings Stock Is Trading Higher - Benzinga

Oct 25, 2024

Oct 25, 2024

enGene secures $60 million in private placement - Investing.com

Oct 25, 2024